| 000 | 03039nam a22005055i 4500 | ||
|---|---|---|---|
| 001 | 978-3-642-15742-4 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083747.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 110414s2011 gw | s |||| 0|eng d | ||
| 020 |
_a9783642157424 _9978-3-642-15742-4 |
||
| 024 | 7 |
_a10.1007/978-3-642-15742-4 _2doi |
|
| 050 | 4 | _aRC86-88.9 | |
| 072 | 7 |
_aMMKL _2bicssc |
|
| 072 | 7 |
_aMED015000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.028 _223 |
| 100 | 1 |
_aAzoulay, Elie. _eeditor. |
|
| 245 | 1 | 0 |
_aPulmonary Involvement in Patients with Hematological Malignancies _h[electronic resource] / _cedited by Elie Azoulay. |
| 264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2011. |
|
| 300 |
_aXIX, 827p. 161 illus., 63 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aPreamble and Introduction.-Epidemiology -- Diagnostic Strategy in Hematologic Malignancies Patients -- Lung Infections in Patients with Hematologic Malignancies.-Noninfectious Pulmonary Involvement in Patients with Hematologic Malignancies -- Treatment and Difficult Decisions in Patients with Hematologic Malignancies.-Pearls that You Should be Aware of.-Post Face. | |
| 520 | _aThe number of patients treated for hematological malignancies is increasing steadily. To obtain the highest possible cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially; however, this has been achieved at the price of life-threatening toxic and infectious complications that chiefly target the lung. This book provides clinicians caring for patients with hematological malignancies with detailed, up-to-date information on all relevant aspects of pulmonary involvement. Individual sections are devoted to epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Each of these sections contains a number of chapters, all written by leading international experts. In addition, the reader’s attention is drawn to important "pearls" relating to each condition. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aCritical care medicine. | |
| 650 | 0 | _aHematology. | |
| 650 | 0 | _aEmerging infectious diseases. | |
| 650 | 0 | _aPneumology. | |
| 650 | 0 | _aOncology. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aIntensive / Critical Care Medicine. |
| 650 | 2 | 4 | _aHematology. |
| 650 | 2 | 4 | _aOncology. |
| 650 | 2 | 4 | _aInfectious Diseases. |
| 650 | 2 | 4 | _aPneumology/Respiratory System. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783642157417 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-642-15742-4 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c107080 _d107080 |
||